Analyzing DiaSorin (OTCMKTS:DSRLF) & Semperit Ag Hld (OTCMKTS:SEIGY)

DiaSorin (OTCMKTS:DSRLF) and Semperit Ag Hld (OTCMKTS:SEIGY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Analyst Recommendations

This is a breakdown of current ratings for DiaSorin and Semperit Ag Hld, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DiaSorin	0	4	2	0	2.33
Semperit Ag Hld	0	0	0	0	0.00

Valuation and Earnings

This table compares DiaSorin and Semperit Ag Hld”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DiaSorin	$1.28 billion	2.86	$203.55 million	N/A	N/A
Semperit Ag Hld	$749.22 million	0.48	$470,000.00	$0.25	17.64

DiaSorin has higher revenue and earnings than Semperit Ag Hld.

Volatility & Risk

DiaSorin has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, Semperit Ag Hld has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500.

Profitability

This table compares DiaSorin and Semperit Ag Hld’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DiaSorin	N/A	N/A	N/A
Semperit Ag Hld	2.48%	4.17%	1.96%

Summary

DiaSorin beats Semperit Ag Hld on 6 of the 9 factors compared between the two stocks.

About DiaSorin

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.

About Semperit Ag Hld

Semperit Aktiengesellschaft Holding develops, produces, and sells rubber products for the medical and industrial sectors worldwide. It operates through two segments: Semperit Industrial Applications and Semperit Engineered Applications. The company provides hydraulic and industrial hoses; conveyor belts; escalator handrails; profiles for windows, doors and facades, cable car rings, and ski foils; and products for railroad superstructures and toolmaking; and precision liquid silicone parts. It offers handrails; engineered solutions; and provides elastomer and sealing profiles for windows, doors, and facades; and elastomer and wear-resistant protective sheeting. It serves agriculture, bulk transportation systems, construction, manufacturing, health care, mining and port facilities, shipping, packing, household, renewable energy and power generation, process, steel, and automotive industries. Semperit Aktiengesellschaft Holding was founded in 1824 and is headquartered in Vienna, Austria.